Kenvue Inc. (KVUE)
NYSE · Consumer Defensive
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $37.56B
- P/E ratio
- —
- EPS
- —
- Volume
- 8,132,548
- 52-week high
- —
- 52-week low
- —
- Open
- $18.93
- Day high
- $19.08
- Day low
- $18.90
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $15.12B | $1.47B | $0.76 |
| 2024 | $15.46B | $1.03B | $0.54 |
| 2023 | $15.44B | $1.66B | $0.90 |
| 2022 | $15.05B | $2.08B | $1.21 |
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- CEO
- Kirk L. Perry
- Employees
- 22,000
- Country
- US
- IPO date
- May 4, 2023
Similar stocks
Other Consumer Defensive companies
Frequently asked questions
- What is Kenvue Inc.'s stock price today?
- KVUE is trading at $19.02 as of Jul 20, 2026.
- What is Kenvue Inc.'s market cap?
- Kenvue Inc. (KVUE) has a market capitalization of $37.56B.
- Does Kenvue Inc. pay a dividend?
- Yes. In FY2025, Kenvue Inc. paid $0.83 per share in dividends.
- What sector is Kenvue Inc. in?
- Kenvue Inc. operates in the Consumer Defensive sector.